Improved bioavailability of levodopa using floatable spray-coated microcapsules for the management of Parkinson’s disease

Improved bioavailability of levodopa using floatable spray-coated microcapsules for the management of Parkinson’s disease

Oral administration of levodopa (LD) is the gold standard in managing Parkinson’s disease (PD). Although LD is the most effective drug in treating PD, chronic administration of LD induces levodopa-induced dyskinesia. A continuous and sustained provision of LD to the brain could, therefore, reduce pe...

Full description

Bibliographic Details
Main Authors: Baek, Jong-Suep, Tee, Jie Kai, Pang, Yi Yun, Tan, Ern Yu, Lim, Kah Leong, Ho, Han Kiat, Loo, Joachim Say Chye
Other Authors: School of Materials Science & Engineering
Format: Journal Article
Language:English
Published: 2019
Subjects:
Controlled Release
DRNTU::Engineering::Materials
Levodopa-induced Dyskinesia
Online Access:https://hdl.handle.net/10356/92269
http://hdl.handle.net/10220/49468

Internet

https://hdl.handle.net/10356/92269
http://hdl.handle.net/10220/49468

Similar Items